{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T11:14:35Z","timestamp":1790507675139,"version":"4.1.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,10,2]],"date-time":"2020-10-02T00:00:00Z","timestamp":1601596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,10,2]],"date-time":"2020-10-02T00:00:00Z","timestamp":1601596800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Microsatellite instability (MSI) status is routinely assessed in patients with colorectal and endometrial cancers as it contributes to Lynch syndrome initial screening, tumour prognosis and selecting patients for immunotherapy. Currently, standard reference methods recommended for MSI\/dMMR (deficient MisMatch Repair) testing consist of immunohistochemistry and pentaplex PCR-based assays, however, novel molecular-based techniques are emerging. Here, we aimed to evaluate the performance of a custom capture-based NGS method and the Bio-Rad ddPCR and Idylla approaches for the determination of MSI status for theranostic purposes in 30 formalin-fixed paraffin embedded (FFPE) tissue samples from patients with endometrial (n\u2009=\u200915) and colorectal (n\u2009=\u200915) cancers. All samples were previously characterised using IHC and Promega MSI Analysis System and these assays set as golden standard. Overall agreement, sensitivity and specificity of our custom-built NGS panel were 93.30%, 93.75% and 92.86% respectively. Overall agreement, sensitivity and specificity were 100% with the Idylla MSI system. The Bio-Rad ddPCR MSI assay showed a 100% concordance, sensitivity and specificity. The custom capture-based NGS, Bio-Rad ddPCR and Idylla approaches represent viable and complementary options to IHC and Promega MSI Analysis System for the detection of MSI. Bio-Rad ddPCR and Idylla MSI assays accounts for easy and fast screening assays while the NGS approach offers the advantages to simultaneously detect MSI and clinically relevant genomic alterations.<\/jats:p>","DOI":"10.1038\/s41598-020-73421-5","type":"journal-article","created":{"date-parts":[[2020,10,2]],"date-time":"2020-10-02T06:04:52Z","timestamp":1601618692000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":52,"title":["Evaluation of 3 molecular-based assays for microsatellite instability detection in formalin-fixed tissues of patients with endometrial and colorectal cancers"],"prefix":"10.1038","volume":"10","author":[{"given":"Pauline","family":"Gilson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Rouyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Demange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Husson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9line","family":"Bonnet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Salleron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agn\u00e8s","family":"Leroux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Louis","family":"Merlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Harl\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,2]]},"reference":[{"key":"73421_CR1","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s12935-019-1091-8","volume":"20","author":"K Li","year":"2020","unstructured":"Li, K., Luo, H., Huang, L., Luo, H. & Zhu, X. Microsatellite instability: A review of what the oncologist should know. Cancer Cell Int. 20, 16 (2020).","journal-title":"Cancer Cell Int."},{"key":"73421_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4251\/wjgo.v10.i1.1","volume":"10","author":"M Koi","year":"2018","unstructured":"Koi, M., Tseng-Rogenski, S. S. & Carethers, J. M. Inflammation-associated microsatellite alterations: Mechanisms and significance in the prognosis of patients with colorectal cancer. World J. Gastrointest. Oncol. 10, 1\u201314 (2018).","journal-title":"World J. Gastrointest. Oncol."},{"key":"73421_CR3","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/cr.2007.115","volume":"18","author":"G-M Li","year":"2008","unstructured":"Li, G.-M. Mechanisms and functions of DNA mismatch repair. Cell Res. 18, 85\u201398 (2008).","journal-title":"Cell Res."},{"key":"73421_CR4","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1158\/0008-5472.CAN-09-3049","volume":"70","author":"SN Shah","year":"2010","unstructured":"Shah, S. N., Hile, S. E. & Eckert, K. A. Defective mismatch repair, microsatellite mutation bias, and variability in clinical cancer phenotypes. Cancer Res. 70, 431\u2013435 (2010).","journal-title":"Cancer Res."},{"key":"73421_CR5","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1007\/s00204-015-1474-0","volume":"89","author":"H Yamamoto","year":"2015","unstructured":"Yamamoto, H. & Imai, K. Microsatellite instability: An update. Arch. Toxicol. 89, 899\u2013921 (2015).","journal-title":"Arch. Toxicol."},{"key":"73421_CR6","first-page":"535","volume":"35","author":"A Collura","year":"2019","unstructured":"Collura, A. et al. Microsatellite instability and cancer: From genomic instability to personalized medicine. Med. Sci. 35, 535\u2013543 (2019).","journal-title":"Med. Sci."},{"key":"73421_CR7","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1111\/j.1582-4934.2009.00977.x","volume":"14","author":"MG Van Lier","year":"2010","unstructured":"Van Lier, M. G. et al. A review on the molecular diagnostics of Lynch syndrome: A central role for the pathology laboratory. J. Cell. Mol. Med. 14, 181\u2013197 (2010).","journal-title":"J. Cell. Mol. Med."},{"key":"73421_CR8","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1126\/science.aan6733","volume":"357","author":"DT Le","year":"2017","unstructured":"Le, D. T. et al. Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade. Science 357, 409\u2013413 (2017).","journal-title":"Science"},{"key":"73421_CR9","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1093\/jnci\/djh034","volume":"96","author":"A Umar","year":"2004","unstructured":"Umar, A. et al. Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J. Natl. Cancer Inst. 96, 261\u2013268 (2004).","journal-title":"J. Natl. Cancer Inst."},{"key":"73421_CR10","first-page":"35","volume":"11","author":"Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group","year":"2009","unstructured":"Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group. Recommendations from the EGAPP Working Group: Genetic testing strategies in newly diagnosed individuals with colorectal cancer aimed at reducing morbidity and mortality from Lynch syndrome in relatives. Genet. Med. Off. J. Am. Coll. Med. Genet. 11, 35\u201341 (2009).","journal-title":"Genet. Med. Off. J. Am. Coll. Med. Genet."},{"key":"73421_CR11","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/s10897-014-9770-z","volume":"24","author":"S Mange","year":"2015","unstructured":"Mange, S. et al. Creation of a network to promote universal screening for Lynch syndrome: The LynchSyndrome Screening Network. J. Genet. Couns. 24, 421\u2013427 (2015).","journal-title":"J. Genet. Couns."},{"key":"73421_CR12","doi-asserted-by":"publisher","first-page":"e0019","DOI":"10.1097\/MD.0000000000010019","volume":"97","author":"S Kang","year":"2018","unstructured":"Kang, S. et al. The significance of microsatellite instability in colorectal cancer after controlling for clinicopathological factors. Medicine 97, e0019 (2018).","journal-title":"Medicine"},{"key":"73421_CR13","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1056\/NEJM200001133420201","volume":"342","author":"R Gryfe","year":"2000","unstructured":"Gryfe, R. et al. Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer. N. Engl. J. Med. 342, 69\u201377 (2000).","journal-title":"N. Engl. J. Med."},{"key":"73421_CR14","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1200\/JCO.2005.01.086","volume":"23","author":"S Popat","year":"2005","unstructured":"Popat, S., Hubner, R. & Houlston, R. S. Systematic review of microsatellite instability and colorectal cancer prognosis. J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol. 23, 609\u2013618 (2005).","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"73421_CR15","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1200\/JCO.2016.71.9807","volume":"35","author":"AR Sepulveda","year":"2017","unstructured":"Sepulveda, A. R. et al. Molecular biomarkers for the evaluation of colorectal cancer: Guideline from the American Society for Clinical Pathology, College of American Pathologists, Association for Molecular Pathology, and the American Society of Clinical Oncology. J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol. 35, 1453\u20131486 (2017).","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"73421_CR16","doi-asserted-by":"publisher","first-page":"6809","DOI":"10.3748\/wjg.v20.i22.6809","volume":"20","author":"Z Saridaki","year":"2014","unstructured":"Saridaki, Z., Souglakos, J. & Georgoulias, V. Prognostic and predictive significance of MSI in stages II\/III colon cancer. World J. Gastroenterol. 20, 6809\u20136814 (2014).","journal-title":"World J. Gastroenterol."},{"key":"73421_CR17","doi-asserted-by":"publisher","first-page":"e000474","DOI":"10.1136\/esmoopen-2018-000474","volume":"4","author":"E Fountzilas","year":"2019","unstructured":"Fountzilas, E. et al. Prognostic implications of mismatch repair deficiency in patients with nonmetastatic colorectal and endometrial cancer. ESMO Open 4, e000474 (2019).","journal-title":"ESMO Open"},{"key":"73421_CR18","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/nature12113","volume":"497","author":"DA Levine","year":"2013","unstructured":"Levine, D. A. Integrated genomic characterization of endometrial carcinoma. Nature 497, 67\u201373 (2013).","journal-title":"Nature"},{"key":"73421_CR19","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1056\/NEJMoa022289","volume":"349","author":"CM Ribic","year":"2003","unstructured":"Ribic, C. M. et al. Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer. N. Engl. J. Med. 349, 247\u2013257 (2003).","journal-title":"N. Engl. J. Med."},{"key":"73421_CR20","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/nrclinonc.2010.18","volume":"7","author":"M Hewish","year":"2010","unstructured":"Hewish, M., Lord, C. J., Martin, S. A., Cunningham, D. & Ashworth, A. Mismatch repair deficient colorectal cancer in the era of personalized treatment. Nat. Rev. Clin. Oncol. 7, 197\u2013208 (2010).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"73421_CR21","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1200\/JCO.2008.18.2071","volume":"27","author":"MM Bertagnolli","year":"2009","unstructured":"Bertagnolli, M. M. et al. Microsatellite instability predicts improved response to adjuvant therapy with irinotecan, fluorouracil, and leucovorin in stage III colon cancer: Cancer and Leukemia Group B Protocol 89803. J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol. 27, 1814\u20131821 (2009).","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"73421_CR22","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.1056\/NEJMoa1500596","volume":"372","author":"DT Le","year":"2015","unstructured":"Le, D. T. et al. PD-1 blockade in tumors with mismatch-repair deficiency. N. Engl. J. Med. 372, 2509\u20132520 (2015).","journal-title":"N. Engl. J. Med."},{"key":"73421_CR23","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1056\/NEJMp1709968","volume":"377","author":"S Lemery","year":"2017","unstructured":"Lemery, S., Keegan, P. & Pazdur, R. First FDA approval agnostic of cancer site\u2014When a biomarker defines the indication. N. Engl. J. Med. 377, 1409\u20131412 (2017).","journal-title":"N. Engl. J. Med."},{"key":"73421_CR24","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/nature11252","volume":"487","author":"CGA Network","year":"2012","unstructured":"Network, C. G. A. Comprehensive molecular characterization of human colon and rectal cancer. Nature 487, 330\u2013337 (2012).","journal-title":"Nature"},{"key":"73421_CR25","doi-asserted-by":"publisher","first-page":"2500","DOI":"10.1056\/NEJMc1713444","volume":"377","author":"M Yarchoan","year":"2017","unstructured":"Yarchoan, M., Hopkins, A. & Jaffee, E. M. Tumor mutational burden and response rate to PD-1 inhibition. N. Engl. J. Med. 377, 2500\u20132501 (2017).","journal-title":"N. Engl. J. Med."},{"key":"73421_CR26","doi-asserted-by":"publisher","first-page":"5652","DOI":"10.18632\/oncotarget.23790","volume":"9","author":"H Yamashita","year":"2017","unstructured":"Yamashita, H. et al. Microsatellite instability is a biomarker for immune checkpoint inhibitors in endometrial cancer. Oncotarget 9, 5652\u20135664 (2017).","journal-title":"Oncotarget"},{"key":"73421_CR27","first-page":"5248","volume":"58","author":"CR Boland","year":"1998","unstructured":"Boland, C. R. et al. A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: Development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res. 58, 5248\u20135257 (1998).","journal-title":"Cancer Res."},{"key":"73421_CR28","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.1053\/gast.2002.37070","volume":"123","author":"N Suraweera","year":"2002","unstructured":"Suraweera, N. et al. Evaluation of tumor microsatellite instability using five quasimonomorphic mononucleotide repeats and pentaplex PCR. Gastroenterology 123, 1804\u20131811 (2002).","journal-title":"Gastroenterology"},{"key":"73421_CR29","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1093\/annonc\/mdz116","volume":"30","author":"C Luchini","year":"2019","unstructured":"Luchini, C. et al. ESMO recommendations on microsatellite instability testing for immunotherapy in cancer, and its relationship with PD-1\/PD-L1 expression and tumour mutational burden: A systematic review-based approach. Ann. Oncol. Off. J. Eur. Soc. Med. Oncol. 30, 1232\u20131243 (2019).","journal-title":"Ann. Oncol. Off. J. Eur. Soc. Med. Oncol."},{"key":"73421_CR30","doi-asserted-by":"publisher","DOI":"10.1093\/clinchem\/hvaa013","author":"AB Silveira","year":"2020","unstructured":"Silveira, A. B. et al. High-accuracy determination of microsatellite instability compatible with liquid biopsies. Clin. Chem. https:\/\/doi.org\/10.1093\/clinchem\/hvaa013 (2020).","journal-title":"Clin. Chem."},{"key":"73421_CR31","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.jmoldx.2019.12.002","volume":"22","author":"K Zwaenepoel","year":"2020","unstructured":"Zwaenepoel, K. et al. Clinical performance of the Idylla MSI test for a rapid assessment of the DNA microsatellite status in human colorectal cancer. J. Mol. Diagn. 22, 386\u2013395 (2020).","journal-title":"J. Mol. Diagn."},{"key":"73421_CR32","doi-asserted-by":"publisher","first-page":"e316","DOI":"10.1016\/j.clcc.2019.05.006","volume":"18","author":"X Li","year":"2019","unstructured":"Li, X. et al. Evaluation of a fully automated Idylla Test System for microsatellite instability in colorectal cancer. Clin. Colorectal Cancer 18, e316\u2013e323 (2019).","journal-title":"Clin. Colorectal Cancer"},{"key":"73421_CR33","doi-asserted-by":"publisher","first-page":"386","DOI":"10.4132\/jptm.2019.09.25","volume":"53","author":"M Lee","year":"2019","unstructured":"Lee, M. et al. Clinical utility of a fully automated microsatellite instability test with minimal hands-on time. J. Pathol. Transl. Med. 53, 386\u2013392 (2019).","journal-title":"J. Pathol. Transl. Med."},{"key":"73421_CR34","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.jmoldx.2017.11.007","volume":"20","author":"L Zhu","year":"2018","unstructured":"Zhu, L. et al. A novel and reliable method to detect microsatellite instability in colorectal cancer by next-generation sequencing. J. Mol. Diagn. 20, 225\u2013231 (2018).","journal-title":"J. Mol. Diagn."},{"key":"73421_CR35","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1373\/clinchem.2014.223677","volume":"60","author":"SJ Salipante","year":"2014","unstructured":"Salipante, S. J., Scroggins, S. M., Hampel, H. L., Turner, E. H. & Pritchard, C. C. Microsatellite instability detection by next generation sequencing. Clin. Chem. 60, 1192\u20131199 (2014).","journal-title":"Clin. Chem."},{"key":"73421_CR36","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1002\/cam4.1372","volume":"7","author":"A Vanderwalde","year":"2018","unstructured":"Vanderwalde, A., Spetzler, D., Xiao, N., Gatalica, Z. & Marshall, J. Microsatellite instability status determined by next-generation sequencing and compared with PD-L1 and tumor mutational burden in 11,348 patients. Cancer Med. 7, 746\u2013756 (2018).","journal-title":"Cancer Med."},{"key":"73421_CR37","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1038\/nm.4191","volume":"22","author":"RJ Hause","year":"2016","unstructured":"Hause, R. J., Pritchard, C. C., Shendure, J. & Salipante, S. J. Classification and characterization of microsatellite instability across 18 cancer types. Nat. Med. 22, 1342\u20131350 (2016).","journal-title":"Nat. Med."},{"key":"73421_CR38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/PO.17.00084","volume":"2017","author":"S Middha","year":"2017","unstructured":"Middha, S. et al. Reliable pan-cancer microsatellite instability assessment by using targeted next-generation sequencing data. JCO Precis. Oncol. 2017, 1\u201317 (2017).","journal-title":"JCO Precis. Oncol."},{"key":"73421_CR39","doi-asserted-by":"publisher","first-page":"7452","DOI":"10.18632\/oncotarget.13918","volume":"8","author":"EA Kautto","year":"2017","unstructured":"Kautto, E. A. et al. Performance evaluation for rapid detection of pan-cancer microsatellite instability with MANTIS. Oncotarget 8, 7452\u20137463 (2017).","journal-title":"Oncotarget"},{"key":"73421_CR40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/PO.17.00073","volume":"2017","author":"R Bonneville","year":"2017","unstructured":"Bonneville, R. et al. Landscape of microsatellite instability across 39 cancer types. JCO Precis. Oncol. 2017, 1\u201315 (2017).","journal-title":"JCO Precis. Oncol."},{"key":"73421_CR41","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1200\/JCO.18.00283","volume":"37","author":"A Latham","year":"2019","unstructured":"Latham, A. et al. Microsatellite instability is associated with the presence of lynch syndrome pan-cancer. J. Clin. Oncol. 37, 286\u2013295 (2019).","journal-title":"J. Clin. Oncol."},{"key":"73421_CR42","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1093\/bioinformatics\/btz797","volume":"36","author":"F Escudi\u00e9","year":"2020","unstructured":"Escudi\u00e9, F. et al. MIAmS: Microsatellite instability detection on NGS amplicons data. Bioinformatics 36, 1915\u20131916 (2020).","journal-title":"Bioinformatics"},{"key":"73421_CR43","doi-asserted-by":"publisher","first-page":"2141","DOI":"10.1200\/JCO.2015.65.1067","volume":"34","author":"ZK Stadler","year":"2016","unstructured":"Stadler, Z. K. et al. Reliable detection of mismatch repair deficiency in colorectal cancers using mutational load in next-generation sequencing panels. J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol. 34, 2141\u20132147 (2016).","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"73421_CR44","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1001\/jamaoncol.2018.4942","volume":"5","author":"R Cohen","year":"2019","unstructured":"Cohen, R. et al. Association of primary resistance to immune checkpoint inhibitors in metastatic colorectal cancer with misdiagnosis of microsatellite instability or mismatch repair deficiency status. JAMA Oncol. 5, 551\u2013555 (2019).","journal-title":"JAMA Oncol."},{"key":"73421_CR45","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1007\/s11864-015-0348-2","volume":"16","author":"H Kawakami","year":"2015","unstructured":"Kawakami, H., Zaanan, A. & Sinicrope, F. A. MSI testing and its role in the management of colorectal cancer. Curr. Treat. Options Oncol. 16, 30 (2015).","journal-title":"Curr. Treat. Options Oncol."},{"key":"73421_CR46","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.jmoldx.2010.12.004","volume":"13","author":"MS Cicek","year":"2011","unstructured":"Cicek, M. S. et al. Quality assessment and correlation of microsatellite instability and immunohistochemical markers among population- and clinic-based colorectal tumors. J. Mol. Diagn. JMD 13, 271\u2013281 (2011).","journal-title":"J. Mol. Diagn. JMD"},{"key":"73421_CR47","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1097\/01.pas.0000146009.85309.3b","volume":"29","author":"J Shia","year":"2005","unstructured":"Shia, J. et al. Value of immunohistochemical detection of DNA mismatch repair proteins in predicting germline mutation in hereditary colorectal neoplasms. Am. J. Surg. Pathol. 29, 96\u2013104 (2005).","journal-title":"Am. J. Surg. Pathol."},{"key":"73421_CR48","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1136\/jclinpath-2019-205935","volume":"72","author":"L Samaison","year":"2019","unstructured":"Samaison, L., Grall, M., Staroz, F. & Uguen, A. Microsatellite instability diagnosis using the fully automated Idylla platform: Feasibility study of an in-house rapid molecular testing ancillary to immunohistochemistry in pathology laboratories. J. Clin. Pathol. 72, 830\u2013835 (2019).","journal-title":"J. Clin. Pathol."},{"key":"73421_CR49","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s12920-020-00753-6","volume":"13","author":"T Akahane","year":"2020","unstructured":"Akahane, T. et al. Next-generation sequencing analysis of endometrial screening liquid-based cytology specimens: A comparative study to tissue specimens. BMC Med. Genomics 13, 101 (2020).","journal-title":"BMC Med. Genomics"},{"key":"73421_CR50","doi-asserted-by":"publisher","first-page":"e15639","DOI":"10.1200\/JCO.2018.36.15_suppl.e15639","volume":"36","author":"B De Craene","year":"2018","unstructured":"De Craene, B. et al. Detection of microsatellite instability (MSI) in colorectal cancer samples with a novel set of highly sensitive markers by means of the Idylla MSI Test prototype. J. Clin. Oncol. 36, e15639\u2013e15639 (2018).","journal-title":"J. Clin. Oncol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-73421-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-73421-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-73421-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,15]],"date-time":"2024-08-15T06:53:56Z","timestamp":1723704836000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-73421-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,2]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["73421"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-73421-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,2]]},"assertion":[{"value":"15 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"16386"}}